The relationship between serum FGF-23 concentration and insulin resistance, prediabetes and dyslipidemia in obese children and adolescents

---

Atıf İçin Kopyala

Kutluturk Y., Akıncı A., Özerol İ. H., Yoloğlu S.

JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, cilt.32, ss.707-714, 2019 (SCI-Expanded)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 32
• Basım Tarihi: 2019
• Doi Numarası: 10.1515/jpem-2018-0507
• Dergi Adı: JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Sayfa Sayıları: ss.707-714
• İnönü Üniversitesi Adresli: Evet

Özet

Background: Obesity is known to cause metabolic disturbances including insulin resistance, dyslipidemia and alters bone mineralization. The effects of obesity on fibroblast growth factor 23 (FGF-23), which is important in bone mineralization, have not yet been clarified. Our aim was to investigate the association between FGF-23 concentration and obesity-associated dysmetabolism.